Movicol Unidose

Sodium Hydrogen Carbonate, Potassium Chloride, Sodium Chloride, Macrogol 3350, the active ingredients in Movicol Unidose, is an osmotic laxative presented as an oral powder for solution for oral use. It relieves constipation by increasing stool water content in adults and children.

GNH USA supplies Movicol Unidose as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Movicol Unidose, an osmotic laxative, is used to manage conditions involving reduced bowel motility.

- Chronic constipation: helps soften stool and promote regular bowel movements. - Faecal impaction: facilitates evacuation of hardened stool. - Bowel preparation for colonoscopy: provides effective cleansing of the colon.

Common Side Effects: - Abdominal bloating: mild distension of the abdomen. - Nausea: feeling of sickness or urge to vomit. - Flatulence: increased intestinal gas. - Diarrhoea: loose, watery stools. - Stomach cramps: intermittent abdominal pain. - Thirst: increased desire for fluids.

Serious or Rare Side Effects: - Severe electrolyte imbalance: abnormal sodium or potassium levels. - Dehydration: excessive loss of body water. - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Severe abdominal pain: persistent, intense pain. - Blood in stool: presence of visible blood. - Renal dysfunction: impaired kidney function.

Before using Movicol Unidose, consider the following safety measures. - Assess renal function: evaluate kidney status before initiating therapy. - Monitor electrolytes: watch for sodium and potassium changes during prolonged use. - Use caution in dehydration: ensure adequate fluid intake while on treatment. - Avoid in intestinal obstruction: contraindicated in mechanical blockage of the bowel. - Pregnancy and breastfeeding: consult a healthcare professional before use. - Store at room temperature: keep in the original pack, protect from moisture.

Movicol Unidose may interact with other medicines; review the following.

Major Interactions (Avoid): - Lithium: increased risk of toxicity due to altered absorption. - Diuretics: may exacerbate electrolyte disturbances. - Digoxin: risk of altered potassium levels affecting cardiac activity.

Moderate Interactions (Monitor Closely): - Antacids: may affect osmotic balance and reduce efficacy. - Oral antibiotics: possible reduced absorption of the antibiotic. - Warfarin: monitor INR as fluid shifts may influence anticoagulant levels.